| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:81.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Ultrasound Department (K.L.), North Middlesex Hospital; Cardiovascular Haemodynamic Unit (A.M.S.), University Department of Surgery; and University Department of Obstetrics and Gynaecology (P.H.), Royal Free and University College Medical School, University College London and The Royal Free Hospital, London, UK.
Correspondence to Paul Hardiman, University Department of Obstetrics and Gynaecology, Royal Free and University College Medical School, University College London, The Royal Free Hospital, Pond St, London NW3 2QG, UK. E-mail hardiman{at}rfc.ucl.ac.uk
Background The purpose of this study was to assess the elastic properties of the carotid arteries in women with polycystic ovarian syndrome, asymptomatic women with polycystic ovaries, and healthy controls.
Methods and Results We recruited the following 60 subjects: 20 symptomatic women with polycystic ovaries attending the reproductive endocrinology clinics, 20 asymptomatic women with polycystic ovaries attending the family planning clinic, and 20 staff volunteers as healthy controls with normal ovaries on transvaginal scan. Compliance and stiffness index were assessed in the common and internal carotid arteries using duplex ultrasound equipped with an echo-locked arterial walltracking system. Compliance was significantly lower in the common carotid artery in symptomatic and asymptomatic women with polycystic ovaries than in the controls (10.7, 14.1, and 19.2 %mm Hg-1x10-2, respectively). The arterial stiffness index was correspondingly increased (12.3, 10.2, and 6.7, respectively). Similar results were obtained in the internal carotid artery for compliance (10.1, 11.0, and 16.9 %mm Hg-1x10-2, respectively) and stiffness index (14.8, 16.2, and 8.7, respectively).
Conclusions The results of this study provide additional evidence of vascular dysfunction in women with polycystic ovaries and are compatible with the hypothesis that they are at increased risk from coronary artery disease and stroke.
Key Words: carotid arteries cardiovascular disease stroke elasticity hemodynamics
This article has been cited by other articles:
![]() |
L. Moran and H. Teede Metabolic features of the reproductive phenotypes of polycystic ovary syndrome Hum. Reprod. Update, July 1, 2009; 15(4): 477 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hu, A. Leonard, A. Seifalian, and P. Hardiman Vascular dysfunction during pregnancy in women with polycystic ovary syndrome Hum. Reprod., June 1, 2007; 22(6): 1532 - 1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Thakrar, V. P. Patel, G. Hamilton, B. J. Fuller, and A. M. Seifalian Vitreous cryopreservation maintains the viscoelastic property of human vascular grafts FASEB J, May 1, 2006; 20(7): 874 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Topcu, M. Caliskan, E. E. Ozcimen, D. Tok, A. Uckuyu, D. Erdogan, H. Gullu, A. Yildirir, H. Zeyneloglu, and H. Muderrisoglu Do young women with polycystic ovary syndrome show early evidence of preclinical coronary artery disease? Hum. Reprod., April 1, 2006; 21(4): 930 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lakhani, W. Yang, A. Dooley, E. El-Mahdi, M. Sundaresan, S. McLellan, R. Bruckdorfer, A. Leonard, A. Seifalian, and P. Hardiman Aortic function is compromised in a rat model of polycystic ovary syndrome Hum. Reprod., March 1, 2006; 21(3): 651 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lakhani, A. Leonard, A.M. Seifalian, and P. Hardiman Microvascular dysfunction in women with polycystic ovary syndrome Hum. Reprod., November 1, 2005; 20(11): 3219 - 3224. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kravariti, K. K. Naka, S. N. Kalantaridou, N. Kazakos, C. S. Katsouras, A. Makrigiannakis, E. A. Paraskevaidis, G. P. Chrousos, A. Tsatsoulis, and L. K. Michalis Predictors of Endothelial Dysfunction in Young Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5088 - 5095. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.A. Checa, A. Requena, C. Salvador, R. Tur, J. Callejo, J.J. Espinos, F. Fabregues, J. Herrero, and (Reproductive Endocrinology Interest Group of the Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome Hum. Reprod. Update, July 1, 2005; 11(4): 375 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ibanez and F. d. Zegher Flutamide-Metformin plus Ethinylestradiol-Drospirenone for Lipolysis and Antiatherogenesis in Young Women with Ovarian Hyperandrogenism: The Key Role of Metformin at the Start and after More than One Year of Therapy J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 39 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Orio Jr., S. Palomba, T. Cascella, B. De Simone, S. Di Biase, T. Russo, D. Labella, F. Zullo, G. Lombardi, and A. Colao Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4588 - 4593. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Escobar-Morreale, J. I. Botella-Carretero, G. Villuendas, J. Sancho, and J. L. San Millan Serum Interleukin-18 Concentrations Are Increased in the Polycystic Ovary Syndrome: Relationship to Insulin Resistance and to Obesity J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 806 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-S. Cheng, A. Tiwari, A. Boutin, C. P. Denton, C. M. Black, R. Morris, G. Hamilton, and A. M. Seifalian Carotid and femoral arterial wall mechanics in scleroderma Rheumatology, November 1, 2003; 42(11): 1299 - 1305. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |